Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Pulmonary Arterial Hypertension Condition: Normal liver function |
Dose: Tablet – 200 mcg Frequency: twice daily Note: Starting dose. Increase dose by increments of 200 mcg twice daily, usually at weekly intervals, to the highest tolerated dose; not to exceed 1600 mcg twice daily. Route: by mouth. |
|
Indication: Pulmonary Arterial Hypertension Condition: Mild hepatic impairment (Child-Pugh A) |
Dose: Tablet Note: No dosage adjustment required. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not Specified – No dosage adjustment required Note: Renal impairment: No dosage adjustment required |
Administration
- Can be taken with food
- Swallow tablets whole
Side Effect
- Headache (65%)
- Diarrhea (42%)
- Jaw pain (26%)
- Nausea (33%)
- Vomiting (18%)
- Pain in extremity (17%)
- Myalgia (16%)
- Flushing (12%)
- Arthralgia (11%)
- Rash (11%)
- Hemoglobin decreased below 10 g/dL (8.6%)
- Anemia (8%)
- Decreased appetite (6%)
- TSH reduced (up to −0.3 MU/L from a baseline of 2.5 MU/L)
- Symptomatic hypotension
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Strong CYP2C8 inhibitors
|
May result in significant increase in exposure to selexipag and its active metabolite; avoid concomitant administration
|
|
Rifampin
|
Halved exposure to active metabolite; increase dose up to twice of the normal dose when co-administered
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.